Status:
UNKNOWN
Ketamine and Dexmedetomidine Comparative Study
Lead Sponsor:
Sohag University
Conditions:
Post Operative Pain
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
In this study, the investigators will compare the effect of adding ketamine and dexmedetomidine to bupivacaine in US-guided combined sciatic and femoral nerve blocks as regards the onset and duration ...
Detailed Description
The patients will be randomly classified into two groups: Ketamine group (group K):40 ml 0.5%bupivacaine and 0.5 mg\\kg ketamine, Dexmedetomidine group (group D) 40 ml 0.5% bupivacaine and 50µg\\kg d...
Eligibility Criteria
Inclusion
- 50 patients with American Society of Anesthesiologists (ASA) grade I to II, 18 to 60 years of age scheduled for below-knee surgeries, Will be included in the study.
- \-
Exclusion
- Patient refusal.
- Patient with significant neurological, psychiatric or neuromuscular disease.
- Alcoholism.
- Drug abuse.
- Pregnancy or lactating women.
- Suspected Coagulopathy.
- Morbid obesity.
- Known allergy to study medications.
- Septicaemia and local infection at the block site.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06032624
Start Date
December 1 2023
End Date
July 1 2025
Last Update
September 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.